Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE.

Biol Blood Marrow Transplant. 2018 Dec 31. pii: S1083-8791(18)31698-7. doi: 10.1016/j.bbmt.2018.12.765. [Epub ahead of print]

PMID:
30605731
2.

Toxoplasma Encephalitis following Tandem Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature.

Kollu V, Magalhaes-Silverman M, Tricot G, Ince D.

Case Rep Infect Dis. 2018 Nov 11;2018:9409121. doi: 10.1155/2018/9409121. eCollection 2018.

3.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL.

Biol Blood Marrow Transplant. 2018 Nov 10. pii: S1083-8791(18)30698-0. doi: 10.1016/j.bbmt.2018.11.004. [Epub ahead of print]

PMID:
30423480
4.

Dabigatran-Associated Thrombocytopenia.

Rafiullah, de Magalhaes-Silverman M, Perepu U.

Am J Ther. 2018 Nov/Dec;25(6):e701-e704. doi: 10.1097/MJT.0000000000000714. No abstract available.

PMID:
30403387
5.

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE.

Haematologica. 2018 Oct 31. pii: haematol.2018.200121. doi: 10.3324/haematol.2018.200121. [Epub ahead of print]

6.

Laryngeal chloroma heralding relapse of acute myeloid leukemia.

Hoover AC, Anderson CM, Hoffman HT, de Magalhaes Silverman M, Syrbu SI, Smith MC.

J Clin Oncol. 2014 Mar 1;32(7):e18-21. doi: 10.1200/JCO.2012.47.0047. Epub 2014 Jan 13. No abstract available.

PMID:
24419134
7.

Daptomycin nonsusceptible enterococci in hematologic malignancy and hematopoietic stem cell transplant patients: an emerging threat.

Wudhikarn K, Gingrich RD, de Magalhaes Silverman M.

Ann Hematol. 2013 Jan;92(1):129-31. doi: 10.1007/s00277-012-1539-6. Epub 2012 Aug 7. Review. No abstract available.

PMID:
22869090
8.

Outcome of allogeneic stem cell transplantation in myelodysplastic syndrome patients: prognostic implication of monosomal karyotype.

Wudhikarn K, Van Rheeden R, Leopold C, Rattanaumpawan P, Gingrich R, de Magalhaes Silverman M.

Eur J Haematol. 2012 Oct;89(4):294-301. doi: 10.1111/j.1600-0609.2012.01830.x. Epub 2012 Aug 8.

PMID:
22762733
9.

Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma.

Wolf JL, Siegel D, Goldschmidt H, Hazell K, Bourquelot PM, Bengoudifa BR, Matous J, Vij R, de Magalhaes-Silverman M, Abonour R, Anderson KC, Lonial S.

Leuk Lymphoma. 2012 Sep;53(9):1820-3. doi: 10.3109/10428194.2012.661175. Epub 2012 Mar 1. No abstract available.

PMID:
22288662
10.

Treatment with plerixafor in non-Hodgkin's lymphoma and multiple myeloma patients to increase the number of peripheral blood stem cells when given a mobilizing regimen of G-CSF: implications for the heavily pretreated patient.

Stiff P, Micallef I, McCarthy P, Magalhaes-Silverman M, Weisdorf D, Territo M, Badel K, Calandra G.

Biol Blood Marrow Transplant. 2009 Feb;15(2):249-56. doi: 10.1016/j.bbmt.2008.11.028.

11.

Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis.

Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, Diekema DJ, Pfaller MA.

Clin Infect Dis. 2004 Aug 15;39(4):584-7. Epub 2004 Jul 30.

PMID:
15356827
12.

A fatal case of West Nile virus infection in a bone marrow transplant recipient.

Hiatt B, DesJardin L, Carter T, Gingrich R, Thompson C, de Magalhaes-Silverman M.

Clin Infect Dis. 2003 Nov 1;37(9):e129-31. Epub 2003 Oct 6.

PMID:
14557983
13.

Outcomes of renal transplantation following bone marrow transplantation.

Hamawi K, De Magalhaes-Silverman M, Bertolatus JA.

Am J Transplant. 2003 Mar;3(3):301-5.

14.

A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation.

Lee CK, de Magalhaes-Silverman M, Hayashi M, Schlueter A, Strauss RG, Hohl RJ, Gingrich RD.

Bone Marrow Transplant. 2002 Apr;29(8):647-52.

15.

Prophylactic T cell infusion after T cell-depleted bone marrow transplantation in patients with refractory lymphoma.

Lee CK, de Magalhaes-Silverman M, Hohl RJ, Hayashi M, Buatti J, Wen BC, Schlueter A, Strauss RG, Gingrich RD.

Bone Marrow Transplant. 2002 Apr;29(7):615-20.

16.

Human herpes virus 6 fatal encephalitis in a bone marrow recipient.

De Almeida Rodrigues G, Nagendra S, Lee CK, De Magalhães-Silverman M.

Scand J Infect Dis. 1999;31(3):313-5.

PMID:
10482064
17.

Factors influencing mobilization and engraftment in patients with metastatic breast cancer undergoing PBSC transplantation.

de Magalhaes-Silverman M, Donnenberg AD, Lister J, Rybka W, Wilson J, Ball E.

J Hematother. 1999 Apr;8(2):167-72.

PMID:
10349910
18.

Pneumoperitoneum without peritonitis after allogeneic peripheral blood stem cell transplantation.

de Magalhaes-Silverman M, Simpson J, Ball E.

Bone Marrow Transplant. 1998 Jun;21(11):1153-4.

19.

Busulfan and cyclophosphamide (BU/CY2) as preparative regimen for patients with lymphoma.

de Magalhaes-Silverman M, Lister J, Rybka W, Wilson J, Ball E.

Bone Marrow Transplant. 1997 Apr;19(8):777-81.

20.

Contamination during in vitro processing of bone marrow for transplantation: clinical significance.

Lazarus HM, Magalhaes-Silverman M, Fox RM, Creger RJ, Jacobs M.

Bone Marrow Transplant. 1991 Mar;7(3):241-6.

PMID:
2059759

Supplemental Content

Loading ...
Support Center